State of the technology / What ANT does / What products are on the horizon

Talks

Neural and Intergenerational Markers of Psychopathology Risk in Youth
Lauren K. White, PhD
Done
Personalized therapeutic brain-stimulation with real-time EEG-synchronized TMS
Christoph Zrenner, MD
Done
Optimizing TMS Targeting and Treatment Response in Depression: Insights from Functional Connectivity and Induced Brain Activity Effects
Romain Duprat, PhD
Done
Low-level multisensory processes: from the impact of early life experience to the prediction of higher-order cognition
Micah M. Murray
Done
Insights Offered by Advanced Signal Processing Analysis of High-Density EEG of Term Low-risk Newborns
Dr. RB Govindan
Done
Precision in TMS motor mapping and neuromodulation targeting: Clinical relevance and updates
Dylan Edwards, PhD
Done
How to use biomarkers in closed-loop neuromodulation
Marom Bikson, PhD
Done
Magnetoencephalography (MEG): Considerations vs. EEG for Clinical and Research Applications – A Moving Target?
Timothy P.L. Roberts
Done
A near real-time computational engine for estimating TMS-induced electric fields with applications to mapping and beyond
Evgenii Kim, PhD
Done
High-Intensity Targeted HD-tDCS for Motor Skill Learning
Gavin Hsu
Done

Location: Lecture Hall - 4/10/24, 2:30 PM - 4/10/24, 3:00 PM (US/Eastern) (30 minutes)

Dr. Frank Zanow

Founder and CEO at Neuromotion | eemagine | ANT Neuro | Neuromotion Ventures | braincredible

Dr. Frank Zanow studied Electrical Engineering at TU Ilmenau (Germany) and received his Ph.D. from the University of Twente (The Netherlands) in 1997 in the field of Applied Physics. Since the establishment of ANT Neuro in 1997, Dr. Zanow successfully led and expanded ANT through skillful management, building a great team focused on the development of innovative hardware and software products. The company now operates globally and provides innovative neuroscience and mental health related solutions, which are in continuous evolution to satisfy an ever-growing market.

Between 2014 and 2024, Dr. Zanow was temporarily enrolled as EU researcher at various European universities and remains actively involved in innovation. He is author and co-author of numerous publications related to EEG instrumentation and EEG/MEG applications. To date, Dr. Zanow is the CEO of several entities, which have a strong presence within the global neuroscience and healthcare market.